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Tropepe, V., Hitoshi, S., Sirard, C., Mak, T.W., Rossant, J., and vanbers. In addition, Ids can be direct positive regulators
der Kooy, D. (2001). Neuron 30, 65–78.of cell growth by interacting with multiple cell cycle
Xu, R.H., Chen, X., Li, D.S., Li, R., Addicks, G.C., Glennon, C., Zwaka,components (Norton, 2000).
T.P., and Thomson, J.A. (2002). Nat. Biotechnol. 20, 1261–1264.Previous studies from this lab identified the transcrip-
Yamaguchi, K., Nagai, S., Ninomiya-Tsuji, J., Nishita, M., Tamai, K.,tion factor Nanog as vital for self-renewal, allowing Nanog-
Irie, K., Ueno, N., Nishida, E., Shibuya, H., and Matsumoto, K. (1999).overexpressing ES cells to be maintained without LIF,
EMBO J. 18, 179–187.
although added LIF could still aid their self-renewal.
Ying, Q.-L., Stavridis, M., Griffiths, D., Li, M., and Smith, A. (2003a).
They now find that cells overexpressing Nanog have Nat. Biotechnol. 21, 183–186.
no requirement for additional BMP, while LIF can still
Ying, Q.-L., Nichols, J., Chambers, I., and Smith, A. (2003b). Cell,
enhance their growth. This implies a strong connection this issue, 281–292.
between BMP signaling and Nanog activity, and in fact
they found that Nanog sustains Id expression.
Another gem contained in this paper is the recognition
that BMP signaling, like LIF signaling, has both stimula-
tory and inhibitory effects on self-renewal, leading the Proteolytic Processing
authors to propose that the balance of these may nor-
in Development andmally serve as a protection against runaway cell expan-
sion. Thus, just as LIF signaling stimulates self-renewal Leukemogenesis
via STAT3, and BMP signaling does so via Id, both also
inhibit self-renewal by Erk and p38 activation. Overex-
pression of BMP, even in the presence of LIF, leads to
There are now numerous examples in the hematopoi-differentiation into non-neural fates, further indicating
etic system of genes that are critical for normal hema-that a balance of Smad and STAT signaling determines
topoietic development, but when mutated, rearranged,the choice between self-renewal and differentiation, and
or overexpressed, contribute to leukemogenesis. Twoin this context it is interesting to note that expression
papers in this issue of Cell provide a fascinating twistof Socs3, a negative regulator of cytokine signaling, is
on this paradigm, and suggest that proteolytic pro-enhanced by expression of both BMP and LIF compared
cessing of certain of these genes plays an importantto LIF alone. Exactly how the pro-differentiation versus
role both in development and in leukemogenesis.pro-self-renewal forces are balanced is not clear, but it
These findings also suggest the possibility that prote-appears there are multiple interacting pathways op-
ases may be therapeutic targets in leukemia.erating via Smad and STAT independently, and also
possibly via a Smad/STAT ternary complex.
In summary, the authors have shown that in defined Hsieh et al. (2003a) have studied the role of proteolytic
media, ES cells make neural cells, and that self-renewal processing of the MLL gene product. MLL is a critical
in ES cells is essentially an anti-neurogenic process, upstream effector of HOX gene expression in verte-
driven by the coordinate actions of BMP and STAT3 brates, and is required for normal axial-skeletal transfor-
signaling pathways. These findings strengthen the idea mation (Yu et al., 1998). As discussed in more detail
that BMPs regulate the early choice between neuronal below, MLL is also rearranged by chromosomal translo-
and non-neural fates in mammals, as in Xenopus (Tro- cations in human leukemias, resulting in fusion of N-ter-
pepe et al., 2001), although in ES cells neural differentia- minal MLL sequences with more that 40 different fusion
tion appears not to be a default state, but rather is FGF- partners of diverse function (Ayton and Cleary, 2001).
dependent (Ying et al., 2003a). It seems, then, that even Hsieh et al. (2003a) identified a novel protease, Tas-
as early as the ICM stage, the pluripotent stem cell is pase 1, which cleaves MLL at two conserved D/GADD
balancing between maintaining self and taking on a neu- and D/GVDD sites, generating N-terminal 320 kDa (N320)
ral alter ego, a process which (by Freudian coincidence) and C-terminal 180 kDa (C180) fragments. Taspase 1 is
involves Id. Perhaps these revelations will allow more an endopeptidase that utilizes an N-terminal threonine
rapid pursuit of defined media for generating consistent as the active site nucleophil to proteolyze polypeptide
human ES lines, for which the molecular basis of self- substrates following an aspartic acid residue. Taspase
renewal still remains a mystery (Smith, 2001; Xu et al., 1 is also a member of a diverse superfamily of N-terminal
2002). nucleophile hydrolases (Ntn-hydrolases) that are all acti-
vated as proenzymes by autocatalytic cleavage.
Taspase 1-mediated proteolytic cleavage of MLL hasSally Temple
differential effects in regulation of HOX gene expression.Albany Medical College
For example, knockdown of Taspase 1 using siRNA im-Albany, New York 12208
pairs maintenance of expression of 3 HOX A genes
(HOX A1, A3, A4) that are expressed early, but not ofSelected Reading
late 5 HOX A genes (HOXA9, HOXA10). In contrast,
Burdon, T., Stracey, C., Chambers, I., Nichols, J., and Smith, A. MLL knockdown or Mll null ES cells display more global
(1999). Dev. Biol. 210, 30–43. defects in Hox gene expression.
Iwasaki, S., Iguchi, M., Watanabe, K., Hoshino, R., Tsujimoto, M., These differential effects on HOX gene expression of
and Kohno, M. (1999). J. Biol. Chem. 274, 26503–26510. complete loss of function of MLL versus loss of Taspase
Norton, J.D. (2000). J. Cell Sci. 113, 3897–3905. 1 suggest that proteolytic cleavage of MLL and related
family members by Taspase 1 may provide additionalSmith, A.G. (2001). Annu. Rev. Cell Dev. Biol. 17, 435–462.
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regulatory control of HOX gene expression during devel- moter (reviewed in Westervelt and Ley, 1999) results in
an APL-like phenotype, whereas expression of PML-opment. Evolutionarily distant homologs of MLL that
are present in Metazoa (such as trr [trithorax-related] in RARdirected to the monocytic compartment by CD11b
regulatory elements in transgenic mice does not result inDrosophila) do not contain D/GADD or D/GVDD cleav-
age sites, but have a contiguous four-domain cluster, leukemia. Furthermore, when PML-RAR is retrovirally
transduced into whole bone marrow, only an APL-likePHD4-FYRN-FYRC-SET, that is thought to be essential
for normal function as homeotic regulators. However, disease develops (Minucci et al., 2002). These data sug-
gest that expression of PML-RAR in the promyelocytethese domains are not juxtaposed in MLL and related
family members such as MLL2 that contain consensus compartment provides critical “soil” for development of
the PML-RAR “seed” (Westervelt and Ley, 1999).Taspase 1 cleavage sites. For example, the FYRN do-
main of MLL is in N320, whereas the FYRC and SET Lane and Ley observed specific cleavage products
of PML-RAR in U937 cells, an early myelomonocyticdomains reside in C180, respectively. Proteolytic pro-
cessing of MLL results in formation of a stable hetero- cell line, but not in K562 cells, an erythroleukemia cell
line. Purification identified the activity as a 30 kDadimer with correct subnuclear localization, in which the
N320 FYRN domain interacts directly with the C180 neutral serine protease, and subsequent analysis indi-
cates that of several candidates identified by massFYRC and SET domains, and is required for stability
and correct subnuclear localization of MLL (Hsieh et al., spectrometry, including Cathepsin G (CG) and protein-
ase 3 (PR3), the predominant activity responsible for2003b). Furthermore, analysis of homologs of MLL and
Taspase 1 indicates that proteolytic processing of MLL cleavage observed in U937 cells is that of neutrophil
elastase (NE). These observations were confirmed bothand related family members by Taspase 1 coevolved
as Chordata and Arthropoda arose from the Metazoa. by using purified proteases as well as incubation with
bone marrow extracts derived from mice deficient inTaken together, these observations suggest that proteo-
lytic processing of MLL related family members by Tas- CG, NE, PR3, or DPPI, a dipeptidyl peptidase that is
required for the activation of CG, NE, and PR3. Muta-pase 1 coevolved to enable more complex patterning
during development. tional analysis showed that PML-RAR residues V420
and V432 are the predominant cleavage sites that gener-What implications do these findings have in leukemias
associated with MLL gene rearrangements? MLL fusion ate the observed 58 kDa and 60 kDa cleavage products.
Although there were few biological or biochemical corre-genes, generated as a consequence of chromosomal
translocations involving human chromosome 11q23, lates of cleavage reported, immmunofluorescence with
anti-PML and anti-RAR antibodies shows that PMLfuse N-terminal sequences of MLL to a remarkably di-
verse group of C-terminal fusion partners (Ayton and and RAR signals do not uniformly colocalize in the
nucleus in U937, whereas they did colocalize in the ex-Cleary, 2001). Gene expression profiles indicate that
HOX gene expression is dysregulated in these tumors pected microspeckled pattern in K562 cells. These data
suggest that cleavage alters intracellular localization of(Armstrong et al., 2002, Yeoh et al., 2002). Furthermore,
mice engineered to express various Mll fusion genes the cleaved peptides, and provide additional evidence
that cleavage occurs in vivo and is not an artifact ofdevelop leukemias, and in certain cases, such as the
MLL-ENL fusion, Hox genes have been shown to be post-lysis proteolysis. In addition, cleavage activity was
observed in extracts derived from primary APL leukemicrequired for transformation of hematopoietic cells (Ay-
ton and Cleary, 2003). Collectively, these data indicate cells from humans.
Perhaps the most striking observation related to thethat MLL fusion genes contribute to pathogenesis of
leukemia in part through dysregulated HOX gene ex- role of NE in PML-RAR mediated leukemia is that mice
deficient in NE are protected from development of leuke-pression. Although the transforming mechanisms of
MLL fusion genes are not completely understood, it is mia. Cathepsin G-PML-RAR transgenic mice were
crossed into either NE- or CG-deficient mice, respec-interesting to note that the MLL fusions may mimic an
“uncleavable” MLL gene product that cannot properly tively. There was dramatic, though not complete, protec-
tion from development of leukemia in NE- but not CG-regulate HOX expression in hematopoietic cells, in that
the Taspase 1 cleavage sites are absent in MLL fusion deficient mice. The leukemias that eventually developed
in some NE-deficient mice were indistinguishable fromgenes generated by chromosomal translocations.
Conditional knockin of noncleavable MLL mutants, those observed in wild-type, indicating that alternative
mechanisms may bypass the apparent requirement ofconditional knockout of Taspase 1, and Taspase 1 inhib-
itors should provide further insight into the role of cleav- NE for PML-RAR mediated leukemogenesis.
These data provide an appealing rationale for the pre-age in these biological process, and into the potential
therapeutic value of Taspase inhibitors in treatment of dilection of PML-RAR to be exclusively associated
with an APL phenotype, namely, that promyelocyte-leukemia associated with MLL gene rearrangements.
As an interesting counterpoint to the observations restricted proteolytic activity is required. However, al-
though NE mediated cleavage appears to be importantof Hsieh et al., Lane and Ley report that proteolytic
processing of a leukemogenic fusion gene, PML-RAR, in pathogensis of PML-RARa mediated leukemias, many
questions remain. First, these data do not provide in-is important for its transforming properties in vivo (Lane
and Ley, 2003). These investigators were interested in sight into the mechanism through which cleavage po-
tentiates the leukemia phenotype. Indeed, it is not evenunderstanding the invariant association of the PML-
RAR fusion gene with an acute promyelocytic leukemia clear that the 58 and 60 kDa cleavage products are
the critical players in leukemogenesis. Transcriptional(APL) phenotype. Expression of PML-RAR directed to
the promyelocyte compartment in transgenic mice by repression mediated by PML-RAR through recruitment
of the nuclear corepressor complex has been well char-either the Cathepsin G (He et al., 1997) or MRP8 pro-
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Ayton, P.M., and Cleary, M.L. (2003). Genes Dev. 17, 2298–2307.acterized, as has release of corepression by all-trans-
He, L.S., Tribioloi, C., Rivi, R., Peruzzi, D., Pelicci, P.G., Soares, V.,retinoic acid (ATRA) in therapy of APL. However, the
Cattoretti, G., and Pandolfi, P.P. (1997). Proc. Natl. Acad. Sci. USAeffect of cleavage on these biological activities has not
94, 5302–5307.yet been determined. As a counterpoint, it should be
Hsieh, J.J., Cheng, E.H.-Y., and Korsmeyer, S.J. (2003a). Cell, thisnoted that our current understanding of pathophysiology
issue, 293–303.
of PML-RAR-mediated leukemia has been predicated on
Hsieh, J.J., Ernst, P., Erdjumentt-Bromage, H., Tempst, P., and Kors-expression of the full-length protein, and subsequent
meyer, S.J. (2003b). Mol. Cell. Biol. 23, 186–194.
analyses may need to take into account activities of
Lane, A.A., and Ley, T.J. (2003). Cell, this issue, 305–318.
the cleaved products. Second, these experiments were
Minucci, S., Monestiroli, S., Givara, S., Ronzoni, S., Marchesi, F.,performed using a bcr-1 PML-RAR breakpoint variant.
Insigna, A., Diverio, D., Gasparini, P., Capillo, M., Colombo, E., et
APL may also be associated with a bcr-3 PML-RAR al. (2002). Blood 100, 2989–2995.
variant that lacks the V420 and V432 NE cleavage sites. Westervelt, P., and Ley, T.J. (1999). Blood 93, 2143–2148.
The authors show that this variant is also cleaved by Yeoh, E.J., Ross, M.E., Shurtleff, S.A., Williams, W.K., Patel, D.,
NE, but at different sites. Although this may indicate Mahfouz, R., Behm, R.G., Raimondi, S.C., Relling, M.V., Patel, A.,
that cleavage is the important event rather than the site et al. (2002). Cancer Cell 1, 133–143.
of cleavage, it complicates mutational analysis designed Yu, B.D., Hanson, R.D., Hess, J.L., Horning, S.E., and Korsmeyer,
to test the hypothesis that the cleavage sites are critical S.J. (1998). Proc. Natl. Acad. Sci. USA 95, 10632–10636.
for leukemogenesis. Third, although the available data
argues against post-lysis artifacts, this is very difficult
to definitively exclude short of mutating the putative
cleavage sites, and as noted above this may be difficult
given the presence of several sites. Fourth, it is not clear MoMLV Reverse Transcriptase
where or how NE gains access to PML-RAR, as they Regulates Its Own Expression
are thought to reside in different cellular compartments.
Last, the human APL cell line NB4 containing the PML-
RAR expresses the full-length PML-RAR fusion pro-
tein, and lacks NE activity. These data provide further A precise ratio of Gag:Gag-Pol expression is required
correlation between NE activity and cleavage, but raise for assembly of infectious retroviral virions. In this is-
the question of why a leukemic cell line derived from a sue of Cell, Orlova et al. show that MoMLV reverse
primary leukemia lacks this activity if it is critical for transcriptase binds the translation release factor
leukemogenesis. eRF1, and that this interaction promotes translation
Nonetheless, these findings are provocative, and war- readthrough to make Gag-Pol.
rant additional experimentation to validate the findings,
and to determine the extent to which these observations The retroviral gene gag is expressed both as an indepen-
can be extrapolated to other leukemogenic fusion genes. dent polyprotein and as a fusion with the polyprotein
One enticing possibility is that proteolytic processing encoded by the gene pol. The link between the structural
plays a more important role than previously appreciated components of the virion found in Gag and the viral
in human leukemias. In addition to PML-RAR, there is enzymes found in Pol ensures that these enzymes are
a predilection among other leukemogenic fusion onco- packaged in newly formed viral particles. But why does
genes for association with specific AML subtypes. For the virus require two forms of Gag? Exclusive expression
example, MLL fusions are frequently associated with of Gag results in the assembly and release of virus-like
myelomonocytic leukemias—it may be of interest to see particles. However, these particles fail to infect cells
if there are differences in MLL cleavage by Taspase 1 because they lack the enzymes required for maturation
in this cellular context. Perhaps the most intriguing as- of the virion and for replication. On the other hand, over-
pect of these two reports is the unexpectedly important expression of Gag-Pol inhibits assembly, possibly due
role that proteolytic processing plays in these develop- to the steric constraints of having Pol on the C terminus
mental and leukemogenic processes. Finally, these data of Gag (Swanstrom and Wills, 1997), and can prevent
suggest that certain proteases should be explored as the packaging of two copies of the viral RNA (Shehu-
potential therapeutic targets in leukemia. Xhilaga et al., 2001). Thus, a delicate balance between
the expression of Gag and Gag-Pol is critical for infec-
tion and is carefully maintained by most retroviruses at
D. Gary Gilliland
a ratio close to 20:1(Shehu-Xhilaga et al., 2001).
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For Moloney murine leukemia virus (MoMLV), the gagArmstrong, S.A., Staunton, J.E., Silverman, L.B., Pieters, R., den
and pol genes are in-frame, and suppression of the stopBoer, M.L., Minden, M.D., Sallan, S.E., Lander, E.S., Golub, T.R.,
and Korsmeyer, S.J. (2002). Nat. Genet. 30, 41–47. codon separating them permits the expression of Gag-
Pol. Although much has been learned about the viralAyton, P.M., and Cleary, M.L. (2001). Oncogene 20, 5695–5707.
